Navigation Links
UT rheumatologists discover 2 genes related to disabling form of arthritis
Date:10/21/2007

HOUSTON (Oct. 22, 2007)Work done in part by researchers at The University of Texas Medical School at Houston has led to the discovery of two genes that cause ankylosing spondylitis, an inflammatory and potentially disabling disease. The findings are published in the Oct. 21 online edition of Nature Genetics, a journal that emphasizes research on the genetic basis for common and complex diseases.

John D. Reveille, M.D., professor and director of the Division of Rheumatology and Clinical Immunogenetics, in conjunction with Matthew A. Brown, M.D., professor of immunogenetics at Australias University of Queensland, led research done by the Triple A Spondylitis Consortium Genetic Study (i.e. the TASC or Australo-Anglo-American Spondylitis Consortium).

The international team of researchers worked with investigators from the British Wellcome Trust Case Control Consortium, and together they made the genetic discovery.

Reveille, chief of rheumatology at Memorial Hermann Texas Medical Center, said the discovery of genes ARTS1 and IL23R brings the scientific community two steps closer to fully understanding ankylosing spondylitis or AS, a chronic form of arthritis that attacks the spine and also can target other joints and organs in the body.

Weve long known that the HLA-B27 gene accounts for 40 percent of the overall cause of AS, said Reveille, the principal investigator of TASC. Now we have found two new genes. Together with HLA-B27, these genes account for roughly 70 percent of the overall cause. That means weve almost nailed this disease. Within the next year, I predict we will have identified all the genes that play a role in this insidious disease. There is more exciting news to come.

The recent discovery is based on work from the largest and most comprehensive genome-wide association scan conducted to date. In this part of the research project, investigators were searching for genetic information related to AS, as well as autoimmune thyroid disease/Graves Disease, breast cancer and multiple sclerosis. Reveille, the George S. Bruce, Jr. Professor in Arthritis and Other Rheumatic Diseases, said the most significant findings were in AS, a disease that generally strikes patients in their teens, 20s or 30s.

ARTS1 and IL23R show a new pathway of causation, Reveille said, and this could lead to new therapies for the arthritic condition, which can cause a complete fusion of the spine, leaving patients unable to straighten and bend.

The identification of the two new genes also could help physicians identify patients who are at the highest risk for developing AS.

For example, if you have a family member with AS, a simple blood test would be able to tell us if you are also at risk, Reveille said. We could offer screenings for people with back pain. In the past, the HLA-B27 test was all we had. Now we potentially have more tests.

Steve Haskew, who has lived with AS for thirty years, said the genetic discovery offers hope to patients especially those who are newly diagnosed.

When I first started experiencing problems lower back pain, the aching joints no one could tell me what was wrong, said Haskew, 59, co-leader of an AS support group that meets every other month at the UT Medical School at Houston. It took 10 years before a rheumatologist diagnosed me with AS. Back then, there werent many options. I was told to take anti-inflammatories and stay as active as possible. Its fascinating to see how far weve come and how much has been learned about the disease since then.

The research done by Reveille and his colleague Xiaodong Zhou, M.D., associate professor of medicine in Division of Rheumatology and Clinical Immunogenetics, was supported in part by the Center for Clinical and Translational Sciences (CCTS) at The University of Texas Health Science Center at Houston.

This is a success story for genetics work, and I think it will lead the way for other work to be done, Reveille said.

The Spondylitis Association of America (SAA) oversaw the nationwide recruitment of patients and families for the study.

This is the most significant breakthrough in AS genetic research since HLA-B27 was uncovered 34 years ago, and SAA played a significant role in making the study possible, said SAA Associate Executive Director Laurie Savage, who is co-principal investigator for TASCs administrative core.


'/>"/>

Contact: Meredith Raine
Meredith.Raine@uth.tmc.edu
713-500-3030
University of Texas Health Science Center at Houston
Source:Eurekalert

Related medicine news :

1. Rheumatologists Underestimate the Patients Ability to Work
2. PRIMARY PULMONARY HYPERTENSION GENE DISCOVERED
3. New Way to "See" Genes, Evaluate Effectiveness of Gene Therapies Discovered
4. OHSU Researchers Announce New Discovery
5. Poisonous Parkinsons molecule discovered
6. Discovery of bone gene
7. Genes for Vision discovered
8. Chemists Discover Cation Considered Too Unstable To Exist
9. New breast cancer genes discovered
10. Latest discovery on Autism
11. Bacterial discovery may help CF patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... ... February 05, 2016 , ... Boar’s Head Brand®, one of the ... this weekend’s Big Game. Take the stress out of your party preparation – follow ... happy at every stage of the game. , “The key to hosting a successful ...
(Date:2/5/2016)... ... February 05, 2016 , ... ... CitiDent, announces that it is now welcoming orthodontist, Dr. Amanda Cheng, to ... a complete range of oral health care, including general dentistry, cosmetic treatments, periodontics, ...
(Date:2/5/2016)... (PRWEB) , ... February 05, 2016 , ... ... Care for Patients with Rare Diseases, a continuing medical education (CME) event presented ... the first of its kind—and a first for ACCORD, whose mission is to ...
(Date:2/5/2016)... ... 05, 2016 , ... When one is tired of trying to cram belongings into spare space ... to rent a storage unit, but before hastily spending money on a unit, take these ... more space. But what one is often not told when utilizing these services are some ...
(Date:2/4/2016)... ... February 04, 2016 , ... True Health Initiative (THI), ... the creation of the THI Media Response Team (MRT). The primary mission of the ... and influencers about the fundamentals of healthy, sustainable eating, and other aspects of lifestyle ...
Breaking Medicine News(10 mins):
(Date:2/4/2016)... Feb. 4, 2016  SciClone Pharmaceuticals, Inc. (NASDAQ: ... has entered into a settlement agreement with the ... resolving the SEC,s investigation into possible violations of ... terms of the settlement agreement, SciClone has agreed ... disgorgement, pre-judgment interest and a penalty.  This payment ...
(Date:2/4/2016)... -- Global Immunology Market to 2022 - Large ... growth Summary Immune-mediated inflammatory diseases are ... affect 5–7% of western populations. Although they are ... key patient demographics, they are pathophysiologically linked, being ... inappropriate immune response. Generally, disease-modifying anti-rheumatic drugs, a ...
(Date:2/4/2016)...  Aethlon Medical, Inc. (Nasdaq: AEMD ), ... treat life-threatening diseases, today announced results for the ... 2015. --> --> ... our last quarterly call, we strategically advanced pre-clinical ... to establish the Aethlon Hemopurifier® as a leading ...
Breaking Medicine Technology: